LBF18102HP01: Difference between revisions
No edit summary |
No edit summary |
||
Line 6: | Line 6: | ||
|LipidBank=DFA8067 | |LipidBank=DFA8067 | ||
|LipidMaps=LMFA01040051 | |LipidMaps=LMFA01040051 | ||
|SysName=Methyl-10,12,13,15-bisepidioxy-9- | |SysName=Methyl-10,12,13,15-bisepidioxy-9-hydroperoxy-16-octadecenoic acid | ||
|Common Name=&&Methyl-10,12,13,15-bisepidioxy-9- | |Common Name=&&Methyl-10,12,13,15-bisepidioxy-9-hydroperoxy-16-octadecenoic acid&& | ||
|Mass Spectra=GC-EI-MS(after reduction(PH3P) and TMS-derivatization)[[Reference:Neff_WE:Frankel_EN:Weisleder_D:,Lipids,1982,17,780|{{RelationTable/GetFirstAuthor|Reference:Neff_WE:Frankel_EN:Weisleder_D:,Lipids,1982,17,780}}]]: m/e=259[SMTO=CH(CH2)7COOCH3]; 185[M-259]; GC-EI-MS(after reduction, hydrogenation, and TMS-derivatization)(105): m/e=261[SMTO=CHCH2CH(OTMS)(CH2)2CH3]; 259[SMTO=CH(CH2)7COOCH3] | |Mass Spectra=GC-EI-MS(after reduction(PH3P) and TMS-derivatization)[[Reference:Neff_WE:Frankel_EN:Weisleder_D:,Lipids,1982,17,780|{{RelationTable/GetFirstAuthor|Reference:Neff_WE:Frankel_EN:Weisleder_D:,Lipids,1982,17,780}}]]: m/e=259[SMTO=CH(CH2)7COOCH3]; 185[M-259]; GC-EI-MS(after reduction, hydrogenation, and TMS-derivatization)(105): m/e=261[SMTO=CHCH2CH(OTMS)(CH2)2CH3]; 259[SMTO=CH(CH2)7COOCH3] | ||
|IR Spectra=OOH group: 3700-3150cm^{-1}[bonded], 3530cm^{-1}[free], isolated trans unsaturation: 960cm^{-1}[[Reference:Neff_WE:Frankel_EN:Weisleder_D:,Lipids,1982,17,780|{{RelationTable/GetFirstAuthor|Reference:Neff_WE:Frankel_EN:Weisleder_D:,Lipids,1982,17,780}}]] | |IR Spectra=OOH group: 3700-3150cm^{-1}[bonded], 3530cm^{-1}[free], isolated trans unsaturation: 960cm^{-1}[[Reference:Neff_WE:Frankel_EN:Weisleder_D:,Lipids,1982,17,780|{{RelationTable/GetFirstAuthor|Reference:Neff_WE:Frankel_EN:Weisleder_D:,Lipids,1982,17,780}}]] |
Latest revision as of 14:32, 26 May 2010
LipidBank Top (トップ) |
Fatty acid (脂肪酸) |
Glycerolipid (グリセロ脂質) |
Sphingolipid (スフィンゴ脂質) |
Journals (雑誌一覧) |
How to edit (ページの書き方) |
IDs and Links | |
---|---|
LipidBank | DFA8067 |
LipidMaps | LMFA01040051 |
CAS | |
KEGG | {{{KEGG}}} |
KNApSAcK | {{{KNApSAcK}}} |
mol | LBF18102HP01 |
Methyl-10,12,13,15-bisepidioxy-9-hydroperoxy-16-octadecenoic acid | |
---|---|
![]() | |
Structural Information | |
Methyl-10,12,13,15-bisepidioxy-9-hydroperoxy-16-octadecenoic acid | |
| |
Formula | C19H32O8 |
Exact Mass | 388.20971799999995 |
Average Mass | 388.45258 |
SMILES | C(O1)(C(OO)CCCCCCCC(=O)OC)CC(C(O2)CC(C=CC)O2)O1 |
Physicochemical Information | |
It is produced from a 15-peroxyradical by singlet-oxygen mediated oxidation of linoleate via succesive 1,3-cyclization Frankel_EN Frankel_EN Neff_WE et al.. | |
It reacts with DNA in the presence of Fe ions and ascorbic acid Fujimoto_K et al.. | |
Spectral Information | |
Mass Spectra | GC-EI-MS(after reduction(PH3P) and TMS-derivatization) Neff_WE et al.: m/e=259[SMTO=CH(CH2)7COOCH3]; 185[M-259]; GC-EI-MS(after reduction, hydrogenation, and TMS-derivatization)(105): m/e=261[SMTO=CHCH2CH(OTMS)(CH2)2CH3]; 259[SMTO=CH(CH2)7COOCH3] |
UV Spectra | |
IR Spectra | OOH group: 3700-3150cm-1[bonded], 3530cm-1[free], isolated trans unsaturation: 960cm-1 Neff_WE et al. |
NMR Spectra | 1H-NMR Neff_WE et al.: C2: 2.3ppm; C9: 3.88ppm[C9-10 erythro], 4.17ppm[C9-10 threo]; C10, 12, 13, 15: 4.47ppm; C11, 14: 2.1-2.8ppm; C16: 5.88ppm; C17: 5.35ppm; C18: 1.73ppm; OOH: 8.73ppm[C9-10 erythro], 9.20ppm[C9-10 threo] Neff_WE et al. |
Other Spectra | |
Chromatograms |
[hide]Reported Metabolites, References | |||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|